News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Samer Al Hadidi: Prior Exposure to Belantamab Mafodotin with Idecabtagene Vicluecel in Multiple Myeloma
Samer Al Hadidi/LinkedIn
Mar 18, 2025, 10:01

Samer Al Hadidi: Prior Exposure to Belantamab Mafodotin with Idecabtagene Vicluecel in Multiple Myeloma

Samer Al Hadidi, Assistant professor at UAMS Myeloma Center, posted on LinkedIn about recent paper he and colleagues co-authored, titled “Prior Exposure to Belantamab Mafodotin Influences Outcomes with Idecabtagene Vicluecel in Patients with Multiple Myeloma” published on American Society of Hematology Blood Advances.

Authors: Bhavesh Mohan Lal, Marah Alzubi, Jawad Alrawabdeh, John D. Shaughnessy, Jr, Fenghuang Zhan, Eric R. Siegel, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Samer Al Hadidi

Samer Al Hadidi: Prior Exposure to Belantamab Mafodotin with Idecabtagene Vicluecel in Multiple Myeloma

“Check out recent work published American Society of Hematology Blood Advances.

Prior Exposure to Belantamab, Mafodotin Influences Outcomes with Idecabtagene ,Vicluecel in Patients with Multiple Myeloma.”

American Society of Hematology Blood Advances Bhavesh Mohan Lal cancer Carolina Schinke Eric R. Siegel Fenghuang Zhan Frits Van Rhee Jawad Alrawabdeh John D. Shaughnessy Jr Marah Alzubi Maurizio Zangari multiple myeloma OncoDaily Oncology Samer Al Hadidi Sharmilan Thanendrarajan
Special Coverage
Blog
Jun 24, 2025, 02:29
Uniting Our Voices and Taking Action - Prepare to Connect With the Experts at NCI-Kenya During the Summit
Blog
Jun 23, 2025, 18:55
Elvina Almuradova: What Comes After CDK4/6 Inhibitors in HR+ Metastatic Breast Cancer?
Blog
Jun 23, 2025, 18:11
Wafaa M Rashed: The Countdown Begins for Our Upcoming PAPERI Webinar Series session
Positive
Jun 23, 2025, 17:34
Jasmine Kamboj: Enjoying the Support of Senator Klobuchar’s Office on Many Levels
Blog
Jun 23, 2025, 17:25
Dato' Dr Saunthari Somasundaram: The National Cancer Congress 2025 Has Been Nothing Short of Inspiring
Career
Jun 23, 2025, 17:16
Mercy Sopuruchi Agu Has Been Appointed Patient Navigator and Fundraising Lead at Project PINK BLUE
Blog
Jun 23, 2025, 17:07
Sebastian Szmit: Proud of My Team at ESC Cardio Oncology 2025
Positive
Jun 23, 2025, 16:55
Paul Hakimata: How Memorial Healthcare System is Becoming a Destination for Cancer Care
Science
Jun 23, 2025, 16:36
New Research on Targeted Axillary Radiation in Early Breast Cancer by Ahmed Orabi et al.
Science
Jun 23, 2025, 15:18
Myeloma Paper of the Day, June 23rd, suggested by Robert Orlowski
Oncolibrary
Jun 23, 2025, 13:51
Press Release: Zanzalintinib Plus Atezolizumab Improves Survival in Refractory Metastatic Colorectal Cancer: STELLAR-303 Results
Insight
Jun 23, 2025, 11:20
Goutham Sunny Highlighted PANOVA-3 Phase III Trial on TTFields Plus Chemotherapy in Locally Advanced Pancreatic Cancer